IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-34633-7.html
   My bibliography  Save this article

A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain

Author

Listed:
  • Ji Wang

    (The First Affiliated Hospital, Sun Yat-sen University
    The First Affiliated Hospital, Sun Yat-sen University)

  • Caiguangxi Deng

    (The First Affiliated Hospital, Sun Yat-sen University)

  • Ming Liu

    (The First Affiliated Hospital, Sun Yat-sen University)

  • Yihao Liu

    (Clinical Trials Unit, The First Affiliated Hospital, Sun Yat-sen University)

  • Liubing Li

    (The First Affiliated Hospital, Sun Yat-sen University)

  • Zhangping Huang

    (The First Affiliated Hospital, Sun Yat-sen University)

  • Liru Shang

    (The First Affiliated Hospital, Sun Yat-sen University)

  • Juan Jiang

    (The First Affiliated Hospital, Sun Yat-sen University)

  • Yongyong Li

    (The First Affiliated Hospital, Sun Yat-sen University)

  • Ruohui Mo

    (Clinical Trials Unit, The First Affiliated Hospital, Sun Yat-sen University)

  • Hui Zhang

    (The First Affiliated Hospital, Sun Yat-sen University
    The First Affiliated Hospital, Sun Yat-sen University)

  • Min Liu

    (The First Affiliated Hospital, Sun Yat-sen University)

  • Sui Peng

    (The First Affiliated Hospital, Sun Yat-sen University
    Clinical Trials Unit, The First Affiliated Hospital, Sun Yat-sen University)

  • Haipeng Xiao

    (The First Affiliated Hospital, Sun Yat-sen University)

Abstract

The effectiveness of a 3rd dose of SARS-CoV-2 vaccines waned quickly in the Omicron-predominant period. In response to fast-waning immunity and the threat of Omicron variant of concern (VOC) to healthcare workers (HCWs), we conduct a non-randomized trial (ChiCTR2200055564) in which 38 HCWs volunteer to receive a homologous booster of inactivated vaccines (BBIBP-CorV) 6 months after the 3rd dose. The primary and secondary outcomes are neutralizing antibodies (NAbs) and the receptor-binding domain (RBD)-directed antibodies, respectively. The 4th dose recalls waned immunity while having distinct effects on humoral responses to different antigens. The peak antibody response to the RBD induced by the 4th dose is inferior to that after the 3rd dose, whereas responses to the N-terminal domain (NTD) of spike protein are further strengthened significantly. Accordingly, the 4th dose further elevates the peak level of NAbs against ancestral SARS-CoV-2 and Omicron BA.2, but not BA.1 which has more NTD mutations. No severe adverse events related to vaccination are recorded during the trial. Here, we show that redistribution of immune focus after repeated vaccinations may modulate cross-protective immune responses against different VOCs.

Suggested Citation

  • Ji Wang & Caiguangxi Deng & Ming Liu & Yihao Liu & Liubing Li & Zhangping Huang & Liru Shang & Juan Jiang & Yongyong Li & Ruohui Mo & Hui Zhang & Min Liu & Sui Peng & Haipeng Xiao, 2022. "A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-34633-7
    DOI: 10.1038/s41467-022-34633-7
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-34633-7
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-022-34633-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Fan Wu & Su Zhao & Bin Yu & Yan-Mei Chen & Wen Wang & Zhi-Gang Song & Yi Hu & Zhao-Wu Tao & Jun-Hua Tian & Yuan-Yuan Pei & Ming-Li Yuan & Yu-Ling Zhang & Fa-Hui Dai & Yi Liu & Qi-Min Wang & Jiao-Jiao , 2020. "Author Correction: A new coronavirus associated with human respiratory disease in China," Nature, Nature, vol. 580(7803), pages 7-7, April.
    2. Surender Khurana & Megan Hahn & Elizabeth M. Coyle & Lisa R. King & Tsai-Lien Lin & John Treanor & Andrea Sant & Hana Golding, 2019. "Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans," Nature Communications, Nature, vol. 10(1), pages 1-15, December.
    3. Fan Wu & Su Zhao & Bin Yu & Yan-Mei Chen & Wen Wang & Zhi-Gang Song & Yi Hu & Zhao-Wu Tao & Jun-Hua Tian & Yuan-Yuan Pei & Ming-Li Yuan & Yu-Ling Zhang & Fa-Hui Dai & Yi Liu & Qi-Min Wang & Jiao-Jiao , 2020. "A new coronavirus associated with human respiratory disease in China," Nature, Nature, vol. 579(7798), pages 265-269, March.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Deborah Cromer & Arnold Reynaldi & Ainslie Mitchell & Timothy E. Schlub & Jennifer A. Juno & Adam K. Wheatley & Stephen J. Kent & David S. Khoury & Miles P. Davenport, 2024. "Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates," Nature Communications, Nature, vol. 15(1), pages 1-9, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Irizar, Patricia & Kapadia, Dharmi & Amele, Sarah & Bécares, Laia & Divall, Pip & Katikireddi, Srinivasa Vittal & Kibuchi, Eliud & Kneale, Dylan & McCabe, Ronan & Nazroo, James & Nellums, Laura B. & T, 2023. "Pathways to ethnic inequalities in COVID-19 health outcomes in the United Kingdom: A systematic map," Social Science & Medicine, Elsevier, vol. 329(C).
    2. Mubango Hazel & Muzariri Calvin, 2022. "Employee Engagement and Competitive Advantage during Covid 19 Pandemic in Small to Medium Enterprises, Catering Industry, Harare," International Journal of Research and Innovation in Social Science, International Journal of Research and Innovation in Social Science (IJRISS), vol. 6(4), pages 288-292, April.
    3. Giulia Orilisi & Marco Mascitti & Lucrezia Togni & Riccardo Monterubbianesi & Vincenzo Tosco & Flavia Vitiello & Andrea Santarelli & Angelo Putignano & Giovanna Orsini, 2021. "Oral Manifestations of COVID-19 in Hospitalized Patients: A Systematic Review," IJERPH, MDPI, vol. 18(23), pages 1-19, November.
    4. David Gomez-Zepeda & Danielle Arnold-Schild & Julian Beyrle & Arthur Declercq & Ralf Gabriels & Elena Kumm & Annica Preikschat & Mateusz Krzysztof Łącki & Aurélie Hirschler & Jeewan Babu Rijal & Chris, 2024. "Thunder-DDA-PASEF enables high-coverage immunopeptidomics and is boosted by MS2Rescore with MS2PIP timsTOF fragmentation prediction model," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    5. Francesco Gangi & Eugenio D'Angelo & Lucia Michela Daniele & Nicola Varrone, 2021. "Assessing the impact of socially responsible human resources management on company environmental performance and cost of debt," Corporate Social Responsibility and Environmental Management, John Wiley & Sons, vol. 28(5), pages 1511-1527, September.
    6. Miquel Oliu-Barton & Bary S. R. Pradelski & Nicolas Woloszko & Lionel Guetta-Jeanrenaud & Philippe Aghion & Patrick Artus & Arnaud Fontanet & Philippe Martin & Guntram B. Wolff, 2022. "The effect of COVID certificates on vaccine uptake, health outcomes, and the economy," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    7. Sneha Gautam & Cyril Samuel & Alok Sagar Gautam & Sanjeev Kumar, 2021. "Strong link between coronavirus count and bad air: a case study of India," Environment, Development and Sustainability: A Multidisciplinary Approach to the Theory and Practice of Sustainable Development, Springer, vol. 23(11), pages 16632-16645, November.
    8. Hengrui Liu & Sho Iketani & Arie Zask & Nisha Khanizeman & Eva Bednarova & Farhad Forouhar & Brandon Fowler & Seo Jung Hong & Hiroshi Mohri & Manoj S. Nair & Yaoxing Huang & Nicholas E. S. Tay & Sumin, 2022. "Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    9. Michael Messer, 2022. "Bivariate change point detection: Joint detection of changes in expectation and variance," Scandinavian Journal of Statistics, Danish Society for Theoretical Statistics;Finnish Statistical Society;Norwegian Statistical Association;Swedish Statistical Association, vol. 49(2), pages 886-916, June.
    10. José M. Núñez-Sánchez & Jesús Molina-Gómez & Pere Mercadé-Melé & Santiago Almadana-Abón, 2024. "Boosting Competitiveness Through the Alignment of Corporate Social Responsibility, Strategic Management and Compensation Systems in Technology Companies: A Case Study," Sustainability, MDPI, vol. 16(21), pages 1-15, October.
    11. Alessandro Germani & Livia Buratta & Elisa Delvecchio & Claudia Mazzeschi, 2020. "Emerging Adults and COVID-19: The Role of Individualism-Collectivism on Perceived Risks and Psychological Maladjustment," IJERPH, MDPI, vol. 17(10), pages 1-15, May.
    12. Ioannis Kontoyiannis & Lambros Mertzanis & Athina Panotopoulou & Ioannis Papageorgiou & Maria Skoularidou, 2022. "Bayesian context trees: Modelling and exact inference for discrete time series," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 84(4), pages 1287-1323, September.
    13. Gabriela Dias Noske & Yun Song & Rafaela Sachetto Fernandes & Rod Chalk & Haitem Elmassoudi & Lizbé Koekemoer & C. David Owen & Tarick J. El-Baba & Carol V. Robinson & Glaucius Oliva & Andre Schutzer , 2023. "An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    14. Eugene Song & Jae-Eun Lee & Seola Kwon, 2021. "Effect of Public Empathy with Infection-Control Guidelines on Infection-Prevention Attitudes and Behaviors: Based on the Case of COVID-19," IJERPH, MDPI, vol. 18(24), pages 1-18, December.
    15. Kow-Tong Chen, 2022. "Emerging Infectious Diseases and One Health: Implication for Public Health," IJERPH, MDPI, vol. 19(15), pages 1-4, July.
    16. Sui Zhang & Minghao Wang & Zhao Yang & Baolei Zhang, 2021. "A Novel Predictor for Micro-Scale COVID-19 Risk Modeling: An Empirical Study from a Spatiotemporal Perspective," IJERPH, MDPI, vol. 18(24), pages 1-16, December.
    17. Shujuan Li & Lingli Zhu & Lidan Zhang & Guoyan Zhang & Hongyan Ren & Liang Lu, 2023. "Urbanization-Related Environmental Factors and Hemorrhagic Fever with Renal Syndrome: A Review Based on Studies Taken in China," IJERPH, MDPI, vol. 20(4), pages 1-20, February.
    18. Umit Cirakli & Ibrahim Dogan & Mehmet Gozlu, 2022. "The Relationship Between COVID-19 Cases and COVID-19 Testing: a Panel Data Analysis on OECD Countries," Journal of the Knowledge Economy, Springer;Portland International Center for Management of Engineering and Technology (PICMET), vol. 13(3), pages 1737-1750, September.
    19. Neeltje van Doremalen & Jonathan E. Schulz & Danielle R. Adney & Taylor A. Saturday & Robert J. Fischer & Claude Kwe Yinda & Nazia Thakur & Joseph Newman & Marta Ulaszewska & Sandra Belij-Rammerstorfe, 2022. "ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    20. Jaeyong Lee & Calem Kenward & Liam J. Worrall & Marija Vuckovic & Francesco Gentile & Anh-Tien Ton & Myles Ng & Artem Cherkasov & Natalie C. J. Strynadka & Mark Paetzel, 2022. "X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation," Nature Communications, Nature, vol. 13(1), pages 1-13, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-34633-7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.